The authors examined in vivo the effects of general anesthetics on evoked substance P release (primary afferent excitability) and c-Fos expression (neuronal activation) in superficial dorsal horn. Methods: Rats received saline, propofol (100 mg/kg), pentobarbital (50 mg/kg), isoflurane (2 minimum alveolar concentration), nitrous oxide (66%), or fentanyl (30 μg/kg). During anesthesia, rats received intraplantar 5% formalin (50 μl) to left hind paw. Ten minutes later, rats underwent transcardial perfusion with 4% paraformaldehyde. Substance P release from small primary afferents was assessed by incidence of neurokinin 1 receptor internalization in the superficial dorsal horn. In separate studies, rats were sacrificed after 2 h and c-Fos expression measured. Results: Intraplantar formalin-induced robust neurokinin 1 receptor internalization in ipsilateral dorsal horn (ipsilateral: 54 ± 6% [mean ± SEM], contralateral: 12 ± 2%; P < 0.05; n = 4). Fentanyl, but not propofol, pentobarbital, isoflurane, nor nitrous oxide alone inhibited neurokinin 1 receptor internalization. However, 2 minimum alveolar concentration isoflurane + nitrous oxide reduced neurokinin 1 receptor internalization (27 ± 3%; P < 0.05; n = 5). All agents reduced c-Fos expression (control: 34 ± 4, fentanyl: 8 ± 2, isoflurane: 12 ± 3, nitrous oxide: 11 ± 2, isoflurane + nitrous oxide: 12 ± 1, pentobarbital: 11 ± 2, propofol: 13 ± 3; P < 0.05; n = 3). Conclusion: General anesthetics at anesthetic concentrations block spinal neuron activation through a mechanism that is independent of an effect on small primary afferent peptide release. The effect of fentanyl alone and the synergistic effect of isoflurane and nitrous oxide on substance P release suggest a correlative rationale for the therapeutic use of these anesthetic protocols by blocking nociceptive afferent transmitter release and preventing the initiation of cascade, which is immediately postsynaptic to the primary afferent.
General Anesthetics on Substance P Release these agents in fact alter afferent input. Slice recordings have shown that isoflurane reduces monosynaptic, likely glutamatergic, excitatory postsynaptic potentials in substantia gelatinosa by a presynaptic action. 12 We sought to address this question of whether the volatile and injectable anesthetics at functionally relevant concentration/doses in vivo, alter afferent input by blocking their releasing function. Transient receptor potential vanilloid 1 positive (capsaicin sensitive) afferents are small, high threshold in nature, and considered to be important for the processing of nociceptive information. [13] [14] [15] Spinal μ opiates produce analgesia, 16 a finding consistent with the demonstration of the presynaptic localization of μ opiate receptors on the spinal terminals of these afferents. 17 Consistent with the fact that μ receptors are negatively coupled with voltage sensitive calcium channels that mediate terminal transmitter release, opiates and N-type calcium channel blockers reduce substance P from these peptidergic primary afferents as measured in vivo by extracellular concentrations 18, 19 and by the use of neurokinin 1 receptor (NK1r) internalization. 20, 21 These studies have shown that such dorsal horn internalization is a validated marker for the evoked release of substance P from primary afferents. Thus, in the current work, we sought to determine the effects in vivo of anesthetic concentrations of volatile and injectable agents on the evoked release of substance P from peptidergic primary afferents. Such work would serve to define whether or not general anesthetics at functionally defined concentrations, like other classes of agents which act on the primary afferent terminals, can block afferent terminal release from a nociceptor.
Materials and Methods

Animals
Male Holtzman Sprague-Dawley rats (250-300 g; Harlan, Indianapolis, IN) were used in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication 85-23, Bethesda, MD). The rats were housed in individual standard cages and maintained on a 12-h light/dark cycle (lights on at 07:00 AM). Testing was performed during the light cycle. Food and water were available ad libitum. All activities were performed according to protocols approved by the Institutional Animal Care and Use Committee of the University of California, San Diego, California.
General Anesthetics on Formalin-induced NK1r Internalization
Saline, propofol (100 mg/kg), or pentobarbital (50 mg/ kg) were injected intraperitoneally. As an active control for evoked NK1r internalization, fentanyl citrate (30 µg/kg) was given intraperitoneally. For volatile anesthetic delivery, animals were placed individually in a closed plexiglass container through which oxygen or oxygen plus the anesthetic agent were delivered. Three volatile anesthetic regimens were used:
(1) isoflurane (2 minimum alveolar concentration [MAC]) = 2.4% in a room air/oxygen mixture (1:1), (2) nitrous oxide (N 2 O; 66 with 33% oxygen), (3) 1 MAC isoflurane combined with N 2 O (66%) and oxygen (33%), or (4) 2 MAC isoflurane combined with N 2 O (66%) and oxygen (33%) provided via an anesthetic machine (Ohmeda, Madison, WI). Fifteen minutes after intraperitoneal drug administration, or 10 min after initiation of inhaled anesthetics, rats received an intraplantar injection of formalin (5%, 50 μl) to the left hind paw.
Tissue Preparation and Immunocytochemistry
Spinal cord tissues were prepared and harvested, as described. 21 Ten minutes after formalin injection, rats were anesthetized with beuthanasia (0.5 ml, intraperitoneally), then transcardially perfused with 0.9% NaCl followed by 4% paraformaldehyde in 0.1 M sodium phosphate-buffered saline, pH 7.4. The lumbar spinal cord was harvested and postfixed overnight. After cryoprotection in 30% sucrose, coronal sections were made using a sliding microtome (30 μm). The spinal sections were washed with phosphate-buffered saline then incubated in a rabbit anti-NK1r polyclonal antibody overnight at room temperature. The antibody was diluted to a concentration of 1:3,000 in 0.01 M phosphate-buffered saline containing 10% normal goat serum and 0.3% Triton X-100. After rinsing in phosphate-buffered saline, spinal sections were incubated for 120 min at room temperature in a goat antirabbit secondary antibody (Alexa 488 to identify NK1 receptors) and a goat antimouse secondary antibody (Alexa 594 to identify NeuN) diluted at 1:1,000 in 0.01 M phosphate-buffered saline containing 10% goat serum and 0.3% Triton X-100. The sections were washed and mounted on glass slides and coverslipped with Pro-Long mounting medium.
Behavioral Effects Initiated by Formalin
Given that these animals were typically under a behaviorally disruptive dose of drug, the current studies were not aimed at systematically defining the effects of formalin-evoked flinching. However, we sought to quantify the immediate (<2 min) response to formalin injection into the hind paw by evaluating gross nociceptive behavior according to the following criteria: 0 = no response, 1 = increased muscle tone (tensing), 2 = injected hind paw withdrawal, and 3 = whole body movement.
Quantification of NK1r Internalization
NK1r internalization was quantified using an Olympus BX-51 fluorescence microscope (Olympus Optical, Tokyo, Japan) fitted with a ×60 oil-immersion objective lens. Counting was conducted, as described previously. 20, 21 The field of view was moved throughout lamina I. The focus was moved up and down intermittently through the spinal section to identify labeled neurons. Neuronal profiles that had 10 or PAIN MEDICINE more endosomes in the soma and the contiguous proximal dendrites were considered to have internalized NK1 receptors. In the ispilateral and contralateral dorsal horns, the total number of NK1r-immunoreactive neurons in lamina І, with or without NK1r internalization, was counted and taken as a ratio of cells showing NK1r internalization versus all NK1r-positive cells and then converted into a percentage of NK1r-immunoreactive cells throughout L4-L6. The person performing the counts was blinded to the experimental treatment of each slide. Mean counts from two to five sections per spinal segment were used as representative counts for a given animal. Three to five animals per drug treatment group were used for statistical analysis (n = 3-5). Light microscopic images were taken using Magna FIRE SP (Optronics, Goleta, CA) and processed by Photoshop CS4 (Adobe, San Jose, CA).
Effect of Isoflurane and Nitrous Oxide on Exogenous
Substance P To rule out the possibility that anesthetic agents directly block the NK1r internalization mechanism, the effect of fentanyl and the combination of isoflurane and nitrous oxide on internalization induced by exogenous substance P (intrathecal injection) were examined. Rats were implanted with an intrathecal catheter for drug delivery under general anesthesia in accordance with the previous report. 22, 23 Five to 7 days after the catheterization, substance P (30 nmol) was delivered intrathecally. Twenty minutes after the substance P injection, rats received intraperitoneal fentanyl or a combination of isoflurane (2 MAC) and N 2 O (66%). Fifteen minutes after the initiation of anesthesia, rats were euthanized and fixed. The total number of NK1r-immunoreactive neurons in bilateral spinal lamina І, with or without NK1r internalization, was counted.
Quantification of c-Fos Expression
To evaluate the formalin-induced c-Fos expression in the spinal superficial dorsal horn, with different anesthetic regimens, separate groups of rats were prepared for immunocytochemistry. These rats were anesthetized, as with the NK1r internalization studies. Fifteen minutes after intraperitoneal drug administration or 10 min after initiation of inhaled anesthetics, rats received intraplantar formalin injection (5%, 50 μl) to the left hind paw. After the initial intraperitoneal injection, a second injection of fentanyl, propofol, and pentobarbital was added. Two hours after the formalin injection, rats were given beuthanasia (0.5 ml, intraperitoneally) and underwent transcardial perfusion and harvested, as previously described. 21 Free-floating sections were incubated in a rabbit anti-Fos polyclonal antibody overnight at 4°C. The antibody was diluted to a concentration of 1:5,000 in 0.01 M phosphate-buffered saline containing 10% normal goat serum and 0.3% Triton X-100. After rinsing in phosphate-buffered saline, spinal sections were incubated for 120 min at room temperature in a goat antirabbit secondary antibody (Alexa 546 to identify Fos) diluted at 1:500 in 0.01 M phosphate-buffered saline containing 10% goat serum and 0.3% Triton X-100. All sections were finally rinsed and mounted on glass slides and coverslipped with ProLong mounting medium. Fos-positive neurons in superficial dorsal horn (lamina I and II) of L4-L5 segments were counted blindly. The mean counts from L4-L5 segments of the lumbar spinal cord were used as representative counts for a given animal. Two to three sections per animal were counted. Three animals per drug treatment group were examined (n = 3).
Drug, Antibody, and Materials
Agents were purchased from the following sources: pentobarbital (Lundbeck Inc., Deerfield, IL); propofol (NOVAP-LUS, Irving, TX); naloxone HCl (Sigma Chemical, St. Louis, MO); isoflurane (VETone, Meridian, ID); nitrous oxide (PRAXAIR, Danbury, CT); fentanyl citrate and beuthanasia (Merck Pharmaceuticals, Rahway, NJ). All injectable agents were administered intraperitoneally. The rabbit anti-NK1r polyclonal antibody was purchased from the Advanced Targeting Systems (San Diego, CA). The rabbit anti-Fos polyclonal antibody was purchased Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Secondary Alexa 488-conjugated antibody, Alexa 594-conjugated antibody, Alexa 546-conjugated antibody, and ProLong mounting medium were purchased from Life Technologies (Carlsbad, CA). Triton X-100 was purchased from Sigma-Aldrich (St. Louis, MO). Substance P was obtained from Peninsula Laboratories (San Carlos, CA).
Statistical Analysis
Statistical analysis was performed by Prism 5 (GraphPad, La Jolla, CA). The effects of each general anesthetic on NK1r internalization were analyzed by two-way ANOVA. To detect the differences in the presence of a significant twoway ANOVA, Bonferroni post hoc analysis was conducted. Behavioral differences and c-Fos expression were analyzed by one-way ANOVA, followed by Dunnet post hoc test. In all analyses, probability to detect the difference was set at the 5% level (P < 0.05).
Results
Behavioral Assessment of General Anesthetics
The effects of general anesthetics on the behavioral phenotype observed after formalin injection (5%, 50 μl) to the hind paw were assessed (table 1). Intraperitoneal propofol (100 mg/kg), pentobarbital (50 mg/kg), exposure of isoflurane (2 MAC), and combination of isoflurane and nitrous oxide produced obvious hypnotic effects and loss of the righting reflex, 24 without complications such as dyspnea. Nitrous oxide (66%) alone did not produce any observed hypnotic effects. The immediate response to formalin injection to the hind paw was evaluated on a 4-point scale (0: no response; 3: whole body movement). Combination of 2 MAC isoflurane General Anesthetics on Substance P Release and nitrous oxide attenuated the movement stimulated by formalin injection to the hind paw compared with propofol, 2 MAC isoflurane, nitrous oxide and fentanyl, but displayed no difference compared with pentobarbital and 1 MAC isoflurane + nitrous oxide (behavioral score: propofol, 1.5 ± 0.3, P < 0.05; pentobarbital, 1.3 ± 0.5, P > 0.05; 2 MAC isoflurane, 1.5 ± 0.3, P < 0.05; 2 MAC isoflurane + nitrous oxide, 0.3 ± 0.2; 1 MAC isoflurane + nitrous oxide, 1.3 ± 0.3, P > 0.05; fentanyl, 1.8 ± 0.4, P < 0.01 vs. 2 MAC isoflurane + nitrous oxide, n = 4-6). Fentanyl produced an analgesic, but not a hypnotic effect on rats. Inhalation of nitrous oxide alone had neither hypnotic, nor analgesic effect on formalininduced pain behavior (behavioral score: 3, n = 6).
Intraplantar Formalin Injection Induced NK1r Internalization
NK1r immunoreactivity was typically observed outlining the cell membrane in many superficial dorsal horn neurons ( fig. 1 , A-C). Significant NK1r internalization was not observed in the contralateral dorsal horn to the formalin-injected paw in L4-L6 (12 ± 2%, n = 4; fig. 1 
Effects of General Anesthetics on NK1r Internalization
The effects of general anesthetics on formalin-induced NK1r internalization are shown in figure 2. Intraperitoneal propofol at an equianalgesic dose (100 mg/kg) did not reduce NK1r internalization in ipsilateral dorsal horn (53 ± 1%; P > 0.05 vs. control; n = 3). Similarly, intraperitoneal pentobarbital (50 mg/kg) did not reduce formalin-induced NK1r internalization (45 ± 4%; P > 0.05 vs. control; n = 3). Inhalation of isoflurane at 2 MAC did not alter formalin-induced NK1r internalization in the spinal dorsal horn (49 ± 6%; P > 0.05 vs. control; n = 3). Nitrous oxide did not reduce formalin-induced NK1r internalization (45 ± 4%; P > 0.05 vs. control; n = 3; fig. 2 )
Combination of Isoflurane and Nitrous Oxide on NK1r Internalization
The combinations of isoflurane and nitrous oxide on formalin-induced NK1r internalization are shown in figure 3 . The combination of 2 MAC isoflurane and N 2 O (66%) significantly reduced formalin-induced NK1r internalization in ipsilateral dorsal horn compared with control rats (27 ± 3%; P < 0.001 vs. control; n = 5). Similarly, the combination of 1 MAC isoflurane and nitrous oxide reduced formalin-induced NK1r internalization in ipsilateral dorsal horn (27 ± 5%; P < 0.001 vs. control; n = 3; fig. 3 ). There was no difference in outcome, as determined by NK1r internalization, between these two combination paradigms.
To assess the possible role of opiate receptors in the combination of isoflurane and nitrous oxide effects on NK1r internalization in these rats, intraperitoneal naloxone (1 mg/kg) was administered 15 min before the initiation of inhalation. Ten minutes after the initiation of isoflurane (2 MAC), N 2 O (66%), and O 2 (33%), rats received formalin (5%, 50 μl) injection to the left hind paw. Ten minutes after the formalin injection, rats underwent transcardial perfusion. Intraperitoneal naloxone did not diminish the effect of isoflurane and nitrous oxide on formalin-induced NK1r internalization in the ipsilateral dorsal horn (21 ± 1%; P > 0.05 vs. ipsilateral isoflurane + nitrous oxide; n = 3; fig. 3 ). The contralateral side of NK1r internalization was not evaluated.
Effect of Isoflurane and Nitrous Oxide on Exogenous
Substance P Intrathecal substance P (30 nmol) produced robust NK1r internalization in the bilateral spinal lamina I compared with intrathecal saline rats (saline: 14 ± 3%, n = 3; substance P: PAIN MEDICINE 72 ± 6%; P < 0.0001; n = 4; fig. 4 ). Intraperitoneal fentanyl did not block the internalization induced by exogenous substance P (63 ± 3%; P > 0.05 vs. intrathecal substance P; n = 3). Similarly, the combination of isoflurane and nitrous oxide did not block the internalization induced by exogenous substance P (62 ± 6%; P > 0.05 vs. intrathecal substance P; n = 3).
Effects of General Anesthetics on c-Fos Expression
Unilateral injection of formalin to the hind paw produced significant enhancement in the number of c-Fos expressing neurons in the ipsilateral superficial dorsal horn in L4-L5 compared with the contralateral side (ipsilateral: 34 ± 4, contralateral: 5 ± 2; P < 0.0001; n = 3; fig. 5, A and B) .
Intraperitoneal fentanyl (30 μg/kg) suppressed the c-Fos expression in the ipsilateral superficial dorsal horn (fentanyl: 8 ± 2; P < 0.0001; n = 3). Isoflurane (1 and 2 MAC), N 2 O (66%), the combination of isoflurane (2 MAC) + N 2 O (66%), pentobarbital (50 mg/kg), and propofol (100 mg/kg) all significantly reduced c-Fos expression in the superficial dorsal horn (isoflurane 1 MAC: 15 ± 2, P < 0.001, n = 3; 2 MAC: 12 ± 3, P < 0.001, n = 3; N 2 O: 11 ± 2, P < 0 .001, n = 3; isoflurane + nitrous oxide: 12 ± 1, P < 0.001, n = 3; pentobarbital: 11 ± 2, P < 0.001, n = 3; and propofol: 13 ± 3, P < 0.001, vs. control, n = 3; fig. 5C ).
Discussion
We examined the effect of general anesthetics on primary afferent release in vivo by assessing the spinal release of substance P. This model was chosen for several reasons. (1) Dorsal horn substance P is largely contained and released from small nociceptive primary afferents. (2) This release can be defined in vivo by examining the internalization of the NK1r. Agents acting upon primary afferent terminals such as μ opioids will prevent terminal substance P release. N-type, but not L-or T-type, channel blockers will prevent evoked release from the primary afferent. 21 Other transmitters, such as glutamate, although of interest, are ubiquitously distributed in most excitatory dorsal horn neurons. Hence, changes in spinal glutamate release might occur from both afferents and interneurons and would not permit assessments of changes in afferent terminal function. General Anesthetics on Substance P Release
Substance P Release and NK1r Internalization
Previous work has shown that the paw stimulation evoked internalization of the dorsal horn NK1 receptor reflects upon the release of substance P from the transient receptor potential vanilloid 1 expressing primary afferent terminal. 20, 25, 26 The NK1r is a G protein coupled receptor, which internalizes when occupied by an agonist, with the degree of internalization reflecting the extracellular substance P release from primary afferents. 20, 27 This in vivo release is attenuated by μ opiate receptors (e.g., morphine and fentanyl) and is mediated by N-type voltage-sensitive calcium channels, as evidenced by the inhibitory effects of intrathecal ziconotide. 21 Confirmation that any block of internalization is mediated by changes in presynaptic release, as opposed to a direct effect upon the internalization process, is supported by the observation that treatments blocking evoked internalization (fentanyl, isoflurane + nitrous oxide) did not block internalization evoked by direct activation of NK1 receptors by intrathecal injection of substance P.
Primary Afferent Transmitter Release and General Anesthetic Action
As expected, based on previous work, 20 systemic fentanyl, at a behaviorally efficacious dose, resulted in block of substance P release. Unexpectedly, none of the anesthetics administered alone had any effect upon release. In the absence of an effect upon afferent terminal peptide release, it is interesting to consider the hypothesized mechanisms of general anesthetic action. GABA A Facilitation. Injectable anesthetics, such as propofol and pentobarbital have been reported to regulate membrane excitability by an increase in Cl − conductance mediated by GABA A receptors. 6, 7 Mutations of these ionophores diminish anesthetic potency of propofol. 28 Isoflurane has similarly been shown to augment activation of the GABA A receptor ionophore. 29 However, GABA A receptor agonists, muscimol have no effect upon primary afferent peptide release. 30 Although GABA A receptor ionophores regulate large afferent excitability, 12 such effects on small afferents have not been identified. Potassium Channels. Isoflurane has been shown to enhance the functionality of various potassium channels including the two-P-domain K + channels, TASK (TWIK-related acidsensitive K + channels) and TREK-1 (TWIK-related K + channels), actions which hyperpolarize the membrane. 31 In the absence of an effect upon substance P release, these mechanisms must not serve to block small afferent terminal release at the concentrations defined to be anesthetic in vivo. Calcium Channels. Several inhaled agents, including isoflurane and halothane, have been reported to block N-type 32, 33 and T-type 34 calcium channel function. We 
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showed that intrathecal ziconotide, a blocker of N-type calcium channels, and opiates, which block opening of N-type calcium channels, also blocked dorsal horn substance P release. 21 Despite this covariance, the current study demonstrated that systemic propofol, barbiturates, isoflurane, or nitrous oxide did not block afferent-evoked substance P release, indicating that at anesthetic concentrations, these agents do not regulate spinal N-type channel function in vivo.
Nitrous Oxide and Its Synergistic Interaction with Isoflurane
Neither nitrous oxide at the maximum usable concentrations, nor 2 MAC isoflurane blocked substance P release. Unexpectedly, isoflurane (1 and 2 MAC) and N 2 O (66%) together reduced evoked substance P release. The mechanism of this interaction is unknown. Although previous work has suggested that nitrous oxide may lead to opiate receptor activation, 35 a high dose of naloxone showed no effect upon the suppressed release. The synergistic interaction observed here parallels the behavioral literature. Although some reports refer to the fact that volatiles such as halothane and isoflurane may antagonize nitrous oxide analgesia, 36 we saw no evidence of such a negative effect on substance P release of c-Fos activation here, and nitrous oxide is MAC-sparing, when used with volatile anesthetics. [37] [38] [39] 
General Anesthetics and Evoked c-Fos Expression
Spinal expression of c-Fos is enhanced in the ipsilateral dorsal horn after unilateral nociceptive stimulation. 40, 41 This increase reflects postsynaptic excitation of dorsal horn neurons mediated by primary afferent input (monosynaptic) or through the large dorsal horn interneuronal pools of glutamatergic neurons with excitatory linkages mediated by a variety of glutamate receptors, including those of the N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid subtypes. 42, 43 Our work showed that although none of the general anesthetics at efficacious concentrations had any effect upon primary afferent release, all resulted in a pronounced suppression of evoked spinal c-Fos expression. These results indicate that the anesthetic effects are mediated either by mechanisms involving nonpeptidergic afferent input that is anesthetic sensitive, or their actions are postsynaptic to the primary afferent. These findings are similar to those reported for propofol, but not pentobarbital, given preinjury/stimulation. 9 Isoflurane, but not halothane, administered at concentrations that suppress reflex movement General Anesthetics on Substance P Release (1 MAC) diminish c-Fos expression. 10 High concentrations of isoflurane (1.5 MAC) depressed c-Fos expression in spinal lamina II, whereas fentanyl reduced expression in lamina V. 11 Results with nitrous oxide have been controversial. Although some have reported little or no effect of nitrous oxide, 44, 45 or even an increase, 46 many studies, including the current one, demonstrate that nitrous oxide alone reduced dorsal horn c-Fos expression. 11, 47, 48 Thus, in the current work, nitrous oxide prevented c-Fos expression in superficial dorsal horn (lamina I-II). Hagihira et al. 48 reported that nitrous oxide reduced c-Fos in the neck of dorsal horn (lamina V-X), but not in the superficial layers (laminae I-II). Interestingly, these authors speculated that this differential effect suggested that nitrous oxide did not have any effects on neurons directly driven by afferent input. There are several caveats to the effect of nitrous oxide. First, many cells showing increased c-Fos with nitrous oxide were reported to be GABAergic neurons. 49 Second, if there were any inhibition by nitrous oxide of GABAergic interneurons, this would itself confound any suppressant effects of nitrous oxide on cellular c-Fos expression in neurons postsynaptic to the GABA interneuron.
Overall, the lack of effect of the anesthetics on c-Fos reported here, in conjunction with the literature discussed in the preceding paragraph, emphasize the likelihood that the anesthetic actions mediated at the spinal cord level are directed at targets postsynaptic to the primary afferent. Consistent with this postsynaptic action in vivo propofol depresses slow ventral root potential, otherwise evoked by local injection of substance P, suggesting a site of action on systems postsynaptic to the substance P releasing primary afferent. 50 Other studies have also supported indirectly the likelihood of a postsynaptic effect. 12, 51, 52 Significance of Current Observations Previous work in a variety of models has supported the assertion that the ability of general anesthetics to alter the organized behavioral response or the response of dorsal horn neurons to a noxious stimulus is mediated at the level of the spinal dorsal horn. [53] [54] [55] [56] [57] The current work demonstrates that general anesthetics at concentrations which yield an anesthetic state failed to block release from a peptidergic, typically high threshold, sensory afferent. In contrast, all agents at these concentrations resulted in suppression of evoked c-Fos expression. These results, thus, suggest that although these anesthetics reduce excitation of neurons, which displayed c-Fos expression (many of which are believed to be spinofugal projection neurons), 58 this effect does not result from the block of the small afferent-evoked excitation. We note that failure of these anesthetics to block substance P release suggests that even in the presence of MAC anesthesia, the second-order neurons is still exposed to the activation mediated by of excitatory receptors. Considerable work has shown that such small afferent input can lead to changes in secondorder neuron functions, which underlie facilitated states. Thus, in previous work, we have shown that after intraplantar formalin model, isoflurane delivered only during the early phase 1 flinching does not alter phase 2 flinching. In contrast, early treatment with a μ opiate during only the first phase significantly reduces the magnitude of the second phase. 59, 60 Continuing in this vein, it is important to note that the electrophysiological phenomena of spinal "wind up" requiring extreme surgical interventions (e.g., dissection and laminectomy) is typically examined under general anesthetics. [61] [62] [63] [64] We accordingly hypothesize that in the face of many prototypical general injectable and volatile anesthetics, small afferent traffic continues to result in an activation of second-order neuron and that it is the activation of neuron or interneuron, which is suppressed by anesthetics. Under these conditions, the second order neuron is subject to the initiation of facilitation cascades that lead to persistent changes in spinal excitability.
